173 related articles for article (PubMed ID: 38619711)
1. Drug-Coated Balloon in Acute Coronary Syndromes: Ready for the Prime Time?
Fezzi S; Malakouti S; Sivalingam J; Khater J; Ribichini F; Cortese B
Curr Cardiol Rep; 2024 May; 26(5):359-372. PubMed ID: 38619711
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Drug-Coated Balloons in Patients with Acute Coronary Syndromes and Vulnerable Plaque.
Zhang YB; Liu HD; Xing JH; Chen BW; Zhao YY; Gu HP; Tao HL
Clin Appl Thromb Hemost; 2022; 28():10760296221130063. PubMed ID: 36198017
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
Mangner N; Farah A; Ohlow MA; Möbius-Winkler S; Weilenmann D; Wöhrle J; Linke A; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Scheller B; Jeger RV;
Circ Cardiovasc Interv; 2022 Feb; 15(2):e011325. PubMed ID: 35000455
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.
Shin ES; Jun EJ; Kim S; Kim B; Kim TH; Sohn CB; Her AY; Park Y; Cho JR; Jeong YH; Choi BJ
JACC Cardiovasc Interv; 2023 Feb; 16(3):292-299. PubMed ID: 36609038
[TBL] [Abstract][Full Text] [Related]
5. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
[TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial.
Fahrni G; Scheller B; Coslovsky M; Gilgen N; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Zweiker R; Twerenbold R; Kaiser C; Jeger R;
Clin Res Cardiol; 2020 Sep; 109(9):1114-1124. PubMed ID: 31993736
[TBL] [Abstract][Full Text] [Related]
7. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
[TBL] [Abstract][Full Text] [Related]
8. Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes (SMART-DATE) prospective multicenter randomized trial.
Lee JM; Cho DK; Hahn JY; Song YB; Park TK; Oh JH; Lee JB; Doh JH; Kim SH; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC
Am Heart J; 2016 Dec; 182():1-8. PubMed ID: 27914488
[TBL] [Abstract][Full Text] [Related]
9. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B;
Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease.
Bonaventura K; Leber AW; Sohns C; Roser M; Boldt LH; Kleber FX; Haverkamp W; Dorenkamp M
Clin Res Cardiol; 2012 Jul; 101(7):573-84. PubMed ID: 22350752
[TBL] [Abstract][Full Text] [Related]
11. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
[TBL] [Abstract][Full Text] [Related]
13. Real-life experience of a stent-less revascularization strategy using a combination of excimer laser and drug-coated balloon for patients with acute coronary syndrome.
Harima A; Sairaku A; Inoue I; Nishioka K; Oka T; Nakama Y; Dai K; Ohi K; Hashimoto H; Kihara Y
J Interv Cardiol; 2018 Jun; 31(3):284-292. PubMed ID: 29464846
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
15. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.
Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Mangieri A; Contri R; Stella S; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A
JACC Cardiovasc Interv; 2015 Oct; 8(12):1586-94. PubMed ID: 26386758
[TBL] [Abstract][Full Text] [Related]
16. Drug-Coated Balloon Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention: A Feasibility Study.
Gobić D; Tomulić V; Lulić D; Židan D; Brusich S; Jakljević T; Zaputović L
Am J Med Sci; 2017 Dec; 354(6):553-560. PubMed ID: 29208251
[TBL] [Abstract][Full Text] [Related]
17. Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design.
Gao C; Zhu B; Liu J; Jiang Z; Hu T; Wang Q; Liu Y; Yuan M; Li F; Zhang R; Xia J; Onuma Y; Wang D; Serruys P; Tao L;
BMC Cardiovasc Disord; 2024 Jan; 24(1):62. PubMed ID: 38245724
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial.
Vos NS; Fagel ND; Amoroso G; Herrman JR; Patterson MS; Piers LH; van der Schaaf RJ; Slagboom T; Vink MA
JACC Cardiovasc Interv; 2019 Sep; 12(17):1691-1699. PubMed ID: 31126887
[TBL] [Abstract][Full Text] [Related]
19. Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials.
Verdoia M; Kedhi E; Suryapranata H; Frati G; Biondi-Zoccai G; De Luca G
J Thromb Thrombolysis; 2020 Aug; 50(2):337-354. PubMed ID: 31919736
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
Uskela S; Kärkkäinen JM; Eränen J; Siljander A; Mäntylä P; Mustonen J; Rissanen TT
Catheter Cardiovasc Interv; 2019 Apr; 93(5):893-900. PubMed ID: 30380186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
